FDA Inspection 973314 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009383018

The FDA completed an inspection of Reproductive Medicine Institute on May 27, 2016 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 27, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)